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• Mantle cell lymphoma (MCL) represents a 
heterogenous subtype of non-Hodgkin lymphoma 
(NHL), which can present in three distinct 
clinicopathologic variants: indolent type MCL, classic 
type MCL and blastoid type MCL.
• Despite the different variations, MCL, in general, is 
almost always associated with advanced-stage 
disease at diagnosis, with a strong predilection for 
significant extra-nodal involvement, usually to the 
bone marrow, CNS, peripheral blood and the 
gastrointestinal tract. 
• However, the literature review reveals ocular 
involvement is a more rarely described extra-nodal 
site of involvement by MCL. Among the reported 
cases, the orbit was most commonly involved, 
followed by the eyelid and the lacrimal gland.
• We report a 63-year-old male who presented with a 
nine-month history of progressive symptoms of 
periorbital swelling and eyelid apraxia, causing 
bilateral visual disturbances. The patient was initially 
treated for presumed blepharospasm by his 
ophthalmologist with botulinum toxin injections; 
however, his periorbital edema continued to worsen, 
and he developed a discrete nodule in his right lower 
eyelid.
• Biopsy of the right eyelid nodule revealed classic 
type MCL with immunohistochemical testing positive 
for CD20, CD5, cyclin D1, SOX11 and Ki67 
proliferative index of 40%. Fluorescence in situ 
hybridization (FISH) analysis detected (11;14) 
translocation. 
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• Mantle Cell Lymphoma International Prognostic Index Combined 
Biologic Index (MIPIb) score was calculated to be 6.5 points based 
on his age, ECOG performance status of 0-1, normal serum LDH, 
normal white blood cell count and elevated Ki67 proliferative index, 
stratifying patient into the high-risk group, with an estimated median 
overall survival of 37 months. 
• Due to the bulky MCL involvement in the palpebral conjunctiva 
affecting his vision and eyelid function, he was immediately treated 
with radiation therapy to the bilateral orbits. PET-CT revealed 
adenopathy above and below the diaphragm. Bone marrow biopsy 
revealed focal involvement (5-10%) by MCL. 
• Brain MRI revealed MCL infiltration in the bilateral orbits and 
lacrimal glands. Upper and lower endoscopy revealed multiple 
polyps positive for MCL. Given the advanced stage of the disease 
and his high-risk stratification, he was started on intensive induction 
chemotherapy with rituximab, dexamethasone, cytarabine, and 
carboplatin and received prophylactic intrathecal methotrexate. 
Systemic imaging after completion of four cycles of treatment 
revealed near resolution of the majority of the lymphadenopathy and 
all of the lymph nodes no longer demonstrated any significant 
metabolic activity.
• He completed two additional cycles of systemic chemotherapy and 
is currently being evaluated for autologous hematopoietic stem cell 
transplantation in complete remission-1 given his excellent 
response to treatment, his young age, high-risk disease at 






Figure A, The lid biopsy shows diffuse to vaguely nodular lymphoid infiltrate 
replacing the biopsy.   Figure B, The tumor cells are small to medium sized 
round lymphoid cells. They show round nuclei with variable nuclear membrane 
irregularity, inconspicuous nucleoli and scant cytoplasm. On 
immunohistochemistry the  tumor cells are positive for CD20 (membranous stain) 
Figure C, and Cyclin D1 (nuclear stain), Figure D consistent with mantle cell 
lymphoma staining pattern.
Despite the diffuse and extensive systemic disease, interestingly, our patient 
did not exhibit any constitutional or metastasis-associated symptoms and only 
presented with isolated periorbital swelling. 
Our case emphasizes the rare extra-nodal site of involvement by MCL and 
encourages all medical providers to remain cognizant of the varying ways in 
which MCL can present clinically.
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